Advertisements

New Molecule PP405 Shows Promise as Breakthrough Solution for Hair Loss, Backed by Google Ventures

by Madonna

Hair loss is a common yet deeply impactful condition that, while not life-threatening, can significantly affect an individual’s self-esteem and mental well-being, often leading to anxiety and depression. Given its widespread emotional and psychological effects, it’s no surprise that the U.S. market for hair loss treatments—ranging from shampoos and serums to hair transplants—is valued at an impressive $2.22 billion. This figure excludes pharmaceutical solutions such as Minoxidil and niche therapies like Platelet-Rich Plasma (PRP) treatments.

However, recent research offers new hope for those struggling with age-related or premature hair loss. A team of scientists from UCLA has developed a promising new molecule, PP405, which has shown significant potential in reactivating dormant hair follicles when applied topically. Early trial results have shown minimal side effects, offering a ray of hope to millions worldwide.

Advertisements

The research team has founded Pelage Pharmaceuticals, a medical development company, to bring PP405 to market, with backing from Google Ventures. The molecule works by activating stem cells within hair follicles that have previously been inactive, prompting them to produce new, thick terminal hair. Notably, this process occurs without the fertility-related side effects seen in some existing treatments, like Minoxidil.

Advertisements

In clinical trials, PP405 has been shown to stimulate noticeable hair growth in as little as one week, without any detectable absorption into the bloodstream or systemic effects. This marks a significant improvement over other hair loss treatments that may involve more invasive methods or undesirable side effects.

Advertisements

Currently undergoing phase 2 trials in the U.S., PP405 is expected to undergo further testing before being made available to the public. If successful, the drug is projected to hit the market between 2027 and 2030, offering a new, highly anticipated option for those affected by hair loss.

Advertisements

Related topics:

Advertisements

You may also like

blank
Hairhealthtips is a hair transplant portal for hair loss. The main columns are hair loss, hair care, hair transplant, knowledge, news, etc. 【Contact us: [email protected]

© 2023 Copyright  hairhealthtips.com